We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Events

25 Jul 2025 - 27 Jul 2025

Artificial Spinal Prosthesis Reconstructs Cervical Discs

By HospiMedica International staff writers
Posted on 16 Mar 2021
An innovative disc prosthesis restores disc height and maintains segmental motion in the cervical region of the spine.

The Spineart (Geneva, Switzerland) Baguera C cervical disc prosthesis is designed to maintain the natural behavior of a functional spinal unit by restoring segmental motion and disc height in the cervical spine, following a single-level or two-level discectomy procedure for symptomatic cervical disc disease. More...
The prosthesis, which is made of two titanium plates interconnected by a polyethylene (PE) central core, permits the patient to experience controlled neck mobility in all six degrees of freedom, with independent angular rotations and translational motions.

A sloping anatomical design optimizes fit between the implant and disc space in order to maximize end-plate coverage, with an additional three upper and three lower fins to enhance primary and secondary stability. The guided mobile PE core prevents excessive constraints on the facet joints and significantly lower contact pressure distribution. In addition, the dual titanium plates are coated with Diamolith, a diamond-like-carbon (DLC) product that reduces artifacts under magnetic resonance imaging (MRI), for better postoperative control. Baguera C has received the Euroean Unin CE Mark of approval, and is undergoing a FDA investigational device exemption (IDE) clinical trial.

“The enrollment of the first patient in our Baguera C two-level trial in the United States is an important achievement, made possible by the relentless work of our employees and partner surgeons,” said Jerome Trividic, President of Spineart USA. “We have embarked on an ambitious project to gather additional solid scientific evidence of safety and effectiveness for our Baguera C artificial disc, with the ultimate goal of providing spine surgeons in the U.S. and their patients with new treatment options.”

Disc replacement via arthroplasty has become a common surgical option for treatment of degenerative cervical disc pathologies, and is considered to be a viable alternative to anterior cervical discectomy and fusion (ACDF). The implanted artificial disc functions similar to a joint, allowing for flexion, extension, side bending, and rotation, thus maintaining motion in the treated vertebral segment.

Related Links:
Spineart


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Bipolar Coagulation Generator
Aesculap
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.